Pharming Group Nv Stock Investor Sentiment

PHGUF Stock  USD 0.75  0.07  8.54%   
Roughly 62% of Pharming Group's investor base is looking to short. The analysis of overall sentiment of trading Pharming Group NV pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
Pharming Group pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharming daily returns and investor perception about the current price of Pharming Group NV as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Pharming announces first patient dosed in pediatric clinical trial for ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Pharming N Group welcomes new Chief People Officer - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
iTeos Therapeutics, Inc. Stock Jumps 5.4 percent Will It Continue to ... - msnNOW
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group N.V. Sponsored ADR Soars 14.7 percent Is Further Upside Left in the Stock - Yahoo Fin...
Google News at Macroaxis
over a year ago at news.google.com         
3 Stocks to Watch From the Coal Industry Despite Ongoing Headwinds - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Kidney Transplant Rejection Therapeutics Market Growth Report 2023-2030 105 Pages Report - Benzinga
Google News at Macroaxis
over a year ago at news.google.com         
Hereditary Angioedema Treatment Market Share Report 2023-2030 132 Pages Report - Benzinga
Google News at Macroaxis
over a year ago at news.google.com         
Kidney Transplant Rejection Therapeutics Market Growth 2023 Exploring Latest Industry Insights with ...
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group to participate in September investor conferences - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Fulcrum Therapeutics, AMTD Digital, Hasbro And Other Big Stocks ... - Investing.com UK
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group N.V. Announces First Patient Enrolled in Phase Iii ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S...
Google News at Macroaxis
over a year ago at news.google.com         
Global Lactoferrin Market Size and Forecast Pharming Group NV ... - University City Review
Google News at Macroaxis
over a year ago at news.google.com         
Hereditary Angioedema Market 2023 to Hit Significant Value by ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Prehospital medication dosing deviates from recommended weight ... - Contemporary Pediatrics
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharming Pink Sheet analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.